Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
55M
-
Number of holders
-
64
-
Total 13F shares, excl. options
-
12.2M
-
Shares change
-
+87.1K
-
Total reported value, excl. options
-
$16.9M
-
Value change
-
-$396K
-
Put/Call ratio
-
0.02
-
Number of buys
-
27
-
Number of sells
-
-25
-
Price
-
$1.39
Significant Holders of Akoya Biosciences, Inc. - Common Stock, $0.00001 par value per share (AKYA) as of Q1 2025
74 filings reported holding AKYA - Akoya Biosciences, Inc. - Common Stock, $0.00001 par value per share as of Q1 2025.
Akoya Biosciences, Inc. - Common Stock, $0.00001 par value per share (AKYA) has 64 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12.2M shares
of 55M outstanding shares and own 22.16% of the company stock.
Largest 10 shareholders include Blue Water Life Science Advisors, LP (4.7M shares), BlackRock, Inc. (1.61M shares), VANGUARD GROUP INC (1.39M shares), PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE (671K shares), GEODE CAPITAL MANAGEMENT, LLC (567K shares), STATE STREET CORP (494K shares), JPMORGAN CHASE & CO (412K shares), UBS Group AG (282K shares), PEDDOCK CAPITAL ADVISORS, LLC (235K shares), and NORTHERN TRUST CORP (231K shares).
This table shows the top 64 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.